Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trial von Guo, J., Carvajal, R.D., Dummer, R., Hauschild, A., Daud, A., Bastian, B.C., Markovic, S.N., Queirolo, P., Arance, A., Berking, C., Camargo, V., Herchenhorn, D., Petrella, T.M., Schadendorf, D., Sharfman, W., Testori, A., Novick, S., Hertle, S., Nourry, C., Chen, Q., Hodi, F.S.

Volltext

Major pathologic response on biopsy (MPRbx) in patients with advanced melanoma treated with anti-PD-1: evidence for an early, on-therapy biomarker of response von Stein, J.E., Soni, A., Danilova, L., Cottrell, T.R., Gajewski, T.F., Hodi, F.S., Bhatia, S., Urba, W.J., Sharfman, W.H., Wind-Rotolo, M., Edwards, R., Lipson, E.J., Taube, J.M.

Volltext

The Role of Melanocortin Plasticity in Pain-Related Outcomes After Alcohol Exposure von Sharfman, Nathan, Gilpin, Nicholas W

Volltext

Does Decision Process Matter? A Study Of Strategic Decision-making Effectiveness von Dean, James W, Sharfman, Mark P

Volltext

BRAF -V600 Mutational Status is a Significant Associate of Brain Metastases Recurrence in Patients With Melanoma: A Retrospective Study von Maxwell, R, Ye, X, Bettegowda, C, Sharfman, W, Redmond, K.J, Kleinberg, L.R, Lim, M

Volltext

Imaging and Clinical Profile Following Concurrent Stereotactic Radiation and Immune Therapy for Melanoma Brain Metastases: Preliminary Results von Shen, C, Lin, D.D.M, Redmond, K.J, Link, K, Kummerlowe, M, Douglass, J, Lipson, E.J, Sharfman, W, Bettegowda, C, Lim, M, Kleinberg, L.R

Volltext

22LBA Activity of PD-1 blockade with pembrolizumab as first systemic therapy in patients with advanced Merkel cell carcinoma von Nghiem, P, Bhatia, S, Daud, A, Friedlander, P, Kluger, H, Kohrt, H, Kudchadkar, R, Lipson, E, Lundgren, L, Margolin, K, Reddy, S, Shantha, E, Sharfman, W, Sharon, E, Thompson, J, Topalian, S, Cheever, M

Volltext

LBA62Efficacy and safety of nivolumab (Nivo) + ipilimumab (Ipi) in patients (pts) with recurrent/metastatic (R/M) cervical cancer: Results from CheckMate 358 von Naumann, R W, Oaknin, A, Meyer, T, Lopez-Picazo, J M, Lao, C, Bang, Y-J, Boni, V, Sharfman, W H, Park, J C, Devriese, L A, Harano, K, Chung, C H, Topalian, S L, Zaki, K, Chen, T, Gu, J, Li, B, Barrows, A, Horvath, A, Moore, K N

Volltext

PROCEDURAL RATIONALITY IN THE STRATEGIC DECISION-MAKING PROCESS von Dean Jr, James W., Sharfman, Mark P.

Volltext

Emerging and Mechanism-Based Therapies for Recurrent or Metastatic Merkel Cell Carcinoma von Miller, Natalie J., Bhatia, Shailender, Parvathaneni, Upendra, Iyer, Jayasri G., Nghiem, Paul

Volltext

Conceptualizing and Measuring the Organizational Environment: A Multidimensional Approach von Sharfman, Mark P., Dean, James W.

Volltext

The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies von J W Smith, 2nd, W J Urba, B D Curti, L J Elwood, R G Steis, J E Janik, W H Sharfman, L L Miller, R G Fenton, K C Conlon

Volltext

Major pathologic response on biopsy (MPR bx ) in patients with advanced melanoma treated with anti-PD-1: evidence for an early, on-therapy biomarker of response von Stein, J E, Soni, A, Danilova, L, Cottrell, T R, Gajewski, T F, Hodi, F S, Bhatia, S, Urba, W J, Sharfman, W H, Wind-Rotolo, M, Edwards, R, Lipson, E J, Taube, J M

Volltext

Conditioned Immune Response to Interferon-γ in Humans von Longo, D.L., Duffey, P.L., Kopp, W.C., Heyes, M.P., Alvord, W.G., Sharfman, W.H., Schmidt, P.J., Rubinow, D.R., Rosenstein, D.L.

Volltext

The Effects of Treatment with Interleukin-1α on Platelet Recovery after High-Dose Carboplatin von Smith, John W, Longo, Dan L, Alvord, W. Gregory, Janik, John E, Sharfman, William H, Gause, Barry L, Curti, Brendan D, Creekmore, Stephen P, Holmlund, Jon T, Fenton, Robert G, Sznol, Mario, Miller, Langdon L, Shimizu, Masanao, Oppenheim, Joost J, Fiem, Shelby J, Hursey, Jean C, Powers, Gerry C, Urba, Walter J

Volltext

The Relationship between Procedural Rationality and Political Behavior in Strategic Decision Making von Dean Jr, James W., Sharfman, Mark P.

Volltext

Mental neuropathy (numb chin syndrome). A harbinger of tumor progression or relapse von Burt, Richard K., Sharfman, William H., Karp, Barbara I., Wilson, Wyndham H.

Volltext

A phase II study of bortezomib in the treatment of metastatic malignant melanoma von Markovic, Svetomir N., Geyer, Susan M., Dawkins, Fitzroy, Sharfman, William, Albertini, Mark, Maples, William, Fracasso, Paula M., Fitch, Tom, LoRusso, Patricia, Adjei, Alex A., Erlichman, Charles

Volltext

Safety of reduced infusion times for nivolumab plus ipilimumab (N + I) and nivolumab alone (N) in advanced melanoma von Martin-Algarra, S., Haanen, J.B., Horak, C., Bhatia, S., Ribas, A., Hwu, W.-J., Slingluff, C.L., Sharfman, W.H., Callahan, M., Hodi, F.S., Wolchok, J.D., Luke, J., Young, T.C., Qureshi, A., Urba, W.J.

Volltext

Safety of the natural killer (NK) cell-targeted anti-KIR antibody, lirilumab (liri), in combination with nivolumab (nivo) or ipilimumab (ipi) in two phase 1 studies in advanced ref... von Segal, N.H., Infante, J.R., Sanborn, R.E., Gibney, G.T., Lawrence, D.P., Rizvi, N., Leidner, R., Gajewski, T.F., Bertino, E., Sharfman, W.H., Cooley, S., Topalian, S.L., Urba, W.J., Wolchok, J.D., Gu, X., Passey, C., McDonald, D., Aanur, P., Srivastava, S., Hodi, F.S.

Volltext